Bascom Palmer is consistently ranked as a top ophthalmology center with extensive research and clinical expertise in retinal imaging technologies including OCTA. Their faculty have contributed significantly to the development and clinical validation of widefield OCTA for diabetic retinopathy and other retinal vascular diseases.

Wills Eye Hospital is renowned for its retinal disease research and adoption of cutting-edge imaging modalities. Their retina specialists have published extensively on OCTA applications and have integrated widefield OCTA into clinical practice for improved diagnosis of peripheral retinal vascular abnormalities.

Massachusetts Eye and Ear combines clinical excellence with biomedical engineering research, advancing OCTA technology including widefield imaging. Their interdisciplinary teams have developed novel imaging protocols and quantitative analysis methods for retinal vascular diseases.

Wilmer Eye Institute is a leader in ophthalmic imaging research, including OCT and OCTA. Their work includes clinical studies on the utility of widefield OCTA for peripheral retinal disease detection and integration of imaging data into patient management.

UCSF has a strong clinical and research focus on retinal diseases and imaging. Their investigators have contributed to the understanding of widefield OCTA's role in detecting peripheral retinal vascular changes and have led clinical studies validating its diagnostic utility.